Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04554836
Title MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors TheraOp

colon adenocarcinoma

rectum adenocarcinoma


Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST